Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia.
Ramona WullenkordChristian ReichertsJan-Henrik MikeschJulia MarxKlaus WethmarJörn AlbringSimon CallGeorg LenzMatthias StelljesPublished in: Annals of hematology (2020)